BIOCHEMICAL AND GENETIC ANALYSIS FOR PREDICTION OF BREAST CANCER RISK

• 1. 基于乳腺癌单细胞转录组测序分析的乳腺癌患者复发风险20基因预测模型 [P] . 中国专利： CN112481378A . 2021-03-12
• 2. 一种乳腺癌预后风险预测标志组合物及应用 [P] . 中国专利： CN113355419B . 2022.02.18
• 3. GENETIC OPTIONS OF CHR2 AND CHR16 AS MARKERS FOR APPLICATION IN RISK ASSESSMENT, DIAGNOSTICATION, PREDICTION AND TREATMENT OF BREAST CANCER [P] . EA200970891A1 . 2010-04-30

  机译： CHR2和CHR16的遗传选择作为标志物在乳腺癌风险评估，诊断，预测和治疗中的应用

• 4. GENETIC ANALYSIS FOR STRATIFICATION OF BREAST CANCER RISK [P] . 欧洲知识产权局专利： EP1670942A2 . 2006-06-21

  机译： 乳腺癌风险分层的遗传分析

• 5. GENETIC ANALYSIS FOR STRATIFICATION OF BREAST CANCER RISK [P] . CA2537768A1 . 2005-03-17

  机译： 乳腺癌风险分层的遗传分析

• 1. Differentially expressed genes analysis and target genes prediction of miR-22 in breast cancer [J] . Tao Fan, Chaoqi Wang, Kun Zhang, 中德临床肿瘤学杂志（英文版） . 2021,第002期
• 2. Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls. [J] . Fletcher O, Johnson N, Dos-Santos-Silva I, Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research . 2009,第1期
• 3. European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancer [J] . Rutgers Emiel, Balmana Judith, Beishon Marc, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2019,第期
• 4. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors [J] . Lee Andrew, Mavaddat Nasim, Wilcox Amber N., Genetics in medicine . 2019,第8期
• 5. Genetic Analysis for Breast Cancer Prediction and Diagnosis [C] . Anusha Ganesan, Ganesan Nagabushnam, Anand Paul, International Conference on Orange Technology . 2020
• 6. Expanding preventive breast cancer genetics: From high to moderate risk and from breast to pancreatic cancer. [D] . Young, Erin Lynn. 2016
• 7. Family History Genetic Testing and Clinical Risk Prediction: Pooled Analysis of CHEK2*1100delC in 1828 Bilateral Breast Cancers and 7030 Controls [O] . Olivia Fletcher, Nichola Johnson, Isabel dos Santos Silva, -1
• 8. Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls [O] . Fletcher, Olivia, Johnson, Nichola, dos Santos Silva, Isabel, 2009

• 1. Single-nucleotide polymorphisms based genetic risk score in the prediction of pancreatic cancer risk [J] . Xiao-Yi Wang ,Hai-Tao Chen ,Rong Na . 世界胃肠病学杂志：英文版 . 2020,第22期
• 2. Competing Risks Analysis of African American Breast Cancer Patients [J] . Minh H. Pham ,Ram C. Kafle . 乳腺癌（英文） . 2017,第1期
• 3. Cancer Susceptibility for Male Breast Cancer Assessed by SNP-A Analysis and Risk Alleles of iTP/i53, iMDM/i2, iVEGF/i, iVEGFR/i1, iHIF/i1iA/iand iBRCA/i1 [J] . Sarika Sharma ,Vasudha Sambyal ,Kamlesh Guleria . 乳腺癌(英文) . 2021,第4期
• 4. Genetic Variation of ihTERT/i, Leukocyte Telomere Length and the Risk of Breast Cancer: A Case-Control Study in Egyptian Females [J] . Shaymaa E. El Feky ,Fawziya A. Ibrahim ,Medhat Haroun . 乳腺癌（英文） . 2019,第2期
• 5. 改良型阳性淋巴结比例在乳腺癌患者中的预后作用分析及乳腺癌预测列线图模型的建立与验证 [C] . 温嘉槐 . 中华中医药学会第十五次乳腺病中医、中西医结合学术研讨会 . 2017
• 6. 乳腺癌术后患者住院期间静脉血栓栓塞症风险预测模型的构建 [A] . 李静 . 2020